News Editorial Guidelines

Newsfile publishes quality news stories of interest to the financial community and the general public. Our team may refuse to disseminate a news release for the following reasons:

  • Poor headline - The headline lacked a news angle and/or attribution to the Issuer distributing the news release.
  • Advertisement or SPAM - The news release reads like an advertisement or SPAM. Examples of these words and phrases include FREE, "Make Money", "Don't miss this opportunity!", SALE!!!!
  • Poor newsworthiness - The news release does not have sufficient news value for distribution.
  • Poor writing quality - The press release is poorly written and/or does not make sense.
  • Lack credible contact information - The news release contains incomplete or lack of credible contact information.
  • Keyword spamming - Blatantly excessive keywords or phrases in the headline and body of the news release.
  • Prohibited content - The press release contains prohibited content which may include the following:
    • Personal opinions - we will not distribute content intended to harm or exact personal revenge against a person or group.
    • Blog posts - Blog posts, general interest articles, "open letters" and the like usually lack attribution and/or news value.
    • Defamatory or intent to harm - This content is defined as anything deemed intended to: incite, advocate or express hatred, bigotry, racism or gratuitous violence; promote personal opinions attacking an individual or group; maliciously affect a company's stock; or stalk, defame, defraud, degrade, shame or victimize an individual or group.
    • Sexually explicit content - we do not accept content about sexually explicit material or products. Press releases should not contain references or links to explicitly sexual material, illegal material or profane language.
    • Health supplements - we do not accept content about health supplements or pharmaceuticals for sexual enhancement.
    • Get rich schemes - We do not accept content about how to get rich, networking marketing and MLM schemes.
    • Piggybacking - unauthorized use of another Issuer's name and ticker symbol in the Press Release.
    • Unsubstantiated claims - Unreviewed, unregulated and unsubstiated claims for medicine, surgical treatment or devices that can prevent or cure COVID19.
    • Inappropriate associations - Content that implies false official government association.
    • Unapproved home testing kits - Content that promotes home testing kits for medical conditions that have not received Regulatory Clearance and Approval.